BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deguise MO, Chehade L, Kothary R. Metabolic Dysfunction in Spinal Muscular Atrophy. Int J Mol Sci 2021;22:5913. [PMID: 34072857 DOI: 10.3390/ijms22115913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Djordjevic S, Milic-Rasic V, Brankovic V, Kosac A, Dejanovic-Djordjevic I, Bijelic M, Dimkic-Tomic T, Markovic-Denic L, Kovacevic S, Petrovic H, Vitorovic S, Dobric Z, Zdravkovic V. Serum leptin levels in children and adolescents with spinal muscular atrophy types 2 and 3. Arch Pediatr 2022:S0929-693X(22)00185-3. [PMID: 36109285 DOI: 10.1016/j.arcped.2022.08.015] [Reference Citation Analysis]
2 Long Q, Feng Y, Chen F, Wang W, Ma M, Mao S. Association between serum zinc level and lipid profiles in children with spinal muscular atrophy. Front Nutr 2022;9:960006. [PMID: 36046135 DOI: 10.3389/fnut.2022.960006] [Reference Citation Analysis]
3 Brown SJ, Kline RA, Synowsky SA, Shirran SL, Holt I, Sillence KA, Claus P, Wirth B, Wishart TM, Fuller HR. The Proteome Signatures of Fibroblasts from Patients with Severe, Intermediate and Mild Spinal Muscular Atrophy Show Limited Overlap. Cells 2022;11:2624. [DOI: 10.3390/cells11172624] [Reference Citation Analysis]
4 Meijboom KE, Sutton ER, McCallion E, McFall E, Anthony D, Edwards B, Kubinski S, Tapken I, Bünermann I, Hazell G, Ahlskog N, Claus P, Davies KE, Kothary R, Wood MJA, Bowerman M. Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice. Skelet Muscle 2022;12:18. [PMID: 35902978 DOI: 10.1186/s13395-022-00301-z] [Reference Citation Analysis]
5 Kubinski S, Claus P. Protein Network Analysis Reveals a Functional Connectivity of Dysregulated Processes in ALS and SMA. J Exp Neurosci 2022;17:263310552210877. [DOI: 10.1177/26331055221087740] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Markati T, Fisher G, Ramdas S, Servais L. Risdiplam: an investigational motor neuron-2 (SMN-2) splicing modifier for spinal muscular atrophy (SMA). Expert Opin Investig Drugs 2022. [PMID: 35316106 DOI: 10.1080/13543784.2022.2056836] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lundt S, Ding S. NAD+ Metabolism and Diseases with Motor Dysfunction. Genes (Basel) 2021;12:1776. [PMID: 34828382 DOI: 10.3390/genes12111776] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Chaytow H, Faller KME, Huang YT, Gillingwater TH. Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine. Cell Rep Med 2021;2:100346. [PMID: 34337562 DOI: 10.1016/j.xcrm.2021.100346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]